Search Results

Display Settings
Results per page: 10
Sort By: Date Descending
Filter
  • 1-10 of  116,121 results for ""Antibodies, Viral""

Your Filters

Sort Order : Publication Date Descending
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine.

  • Authors : Shah N; Department of Peadiatrics, P.D Hinduja Hospital & Medical Research Centre, Mumbai, India.; Ghosh A

Subjects: Mumps*/Mumps*/Mumps*/prevention & control ; Measles*/Measles*/Measles*/prevention & control ; Rubella*/Rubella*/Rubella*/prevention & control

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2302685. Date of Electronic Publication: 2024 Jan 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.

Subjects: ChAdOx1 nCoV-19* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Adult

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2304974. Date of Electronic Publication: 2024 Mar 21.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.

  • Authors : Bates JT; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.; Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2308375. Date of Electronic Publication: 2024 Feb 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts.

  • Authors : Chittrakarn S; Division of Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.; Siripaitoon P

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; HIV Infections* ; COVID-19 Vaccines*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2309734. Date of Electronic Publication: 2024 Jan 31.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey.

  • Authors : Wang Q; Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.; Xiu S

Subjects: Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus Vaccines* ; Respiratory Syncytial Virus, Human*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2310916. Date of Electronic Publication: 2024 Feb 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.

  • Authors : Ziemssen T; Department of Neurology, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, University Hospital of Dresden, Technische Universität Dresden, Dresden, Germany.; Groth M

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; Antibodies, Monoclonal, Humanized*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2316422. Date of Electronic Publication: 2024 Feb 12.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China.

  • Authors : Chen S; Biological Products Surveillance and Evaluation, Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, Guangdong, China.; Ying Z

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/prevention & control ; Poliovirus* ; Rotavirus Vaccines*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2324538. Date of Electronic Publication: 2024 Mar 20.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 vaccines: Immune correlates and clinical outcomes.

  • Authors : Mahrokhian SH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Department of Medicine, Tufts University School of Medicine, Boston, MA, USA.

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans SARS-CoV-2 variants

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2324549. Date of Electronic Publication: 2024 Mar 22.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Neutralizing activity of anti-respiratory syncytial virus monoclonal antibody produced in Nicotiana benthamiana .

  • Authors : Pisuttinusart N; Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.; Center of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand.

Subjects: Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus, Human* ; Respiratory Syncytial Virus Vaccines*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2327142. Date of Electronic Publication: 2024 Mar 20.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial.

Subjects: Ebola Vaccines* ; Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/Hemorrhagic Fever, Ebola*/prevention & control ; Ebolavirus*

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2327747. Date of Electronic Publication: 2024 Mar 24.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  116,121 results for ""Antibodies, Viral""